Rocket


Overview
Financials
News + Filings
Key Docs
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Apellis Pharmaceuticals, Inc. (APLS) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/18/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2023 SC 13G T. Rowe Price Investment Management, Inc. reports a 5.3% stake in APELLIS PHARMACEUTICALS INC
02/14/2022 SC 13G PRICE T ROWE ASSOCIATES INC reports a 5.4% stake in Apellis Pharmaceuticals, Inc.
02/11/2022 SC 13G Avoro Capital Advisors LLC reports a 8.9% stake in Apellis Pharmaceuticals, Inc.
02/10/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
01/28/2020 SC 13G WELLINGTON MANAGEMENT GROUP LLP reports a 6.9% stake in Apellis Pharmaceutic
02/14/2019 SC 13G Morningside Venture Investments Ltd reports a 20.6% stake in APELLIS PHARMACEUTICALS, INC.
02/07/2019 SC 13G BlackRock Inc. reports a 6.6% stake in Apellis Pharmaceuticals, Inc.
02/14/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2018 SC 13G venBio Global Strategic Fund II L.P. reports a 7.1% stake in Apellis Pharmaceuticals, Inc.
11/21/2017 SC 13G Cormorant Asset Management, LLC reports a 7% stake in Apellis Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy